Traphagen Investment Advisors LLC Bristol Myers Squibb CO Transaction History

Traphagen Investment Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jun 17, 2024	BUY	$57.89 - $64.73 $201,457 - $225,260	3,480 New	3,480 $202 Million
Q2 2023 Jun 17, 2024	BUY	$63.71 - $70.74 $207,057 - $229,904	3,250 New	3,250 $208 Million
Q1 2023 Jun 17, 2024	BUY	$65.71 - $74.53 $788 - $894	12 Added 0.37%	3,237 $224 Million
Q4 2022 Jun 17, 2024	BUY	$68.48 - $81.09 $220,848 - $261,515	3,225 New	3,225 $232 Million
Q3 2022 Jun 17, 2024	BUY	$0.13 - $76.84 $1 - $768	10 Added 0.32%	3,102 $221 Million
Q2 2022 Jun 17, 2024	BUY	$72.62 - $79.98 $224,541 - $247,298	3,092 New	3,092 $238 Million
Q1 2022 Jun 17, 2024	BUY	$61.48 - $73.72 $110,418 - $132,401	1,796 Added 144.84%	3,036 $222 Million
Q4 2021 Jun 17, 2024	BUY	$53.63 - $62.52 $66,501 - $77,524	1,240 New	1,240 $227 Million
Q2 2021 Jun 17, 2024	SELL	$61.91 - $67.42 $165,485 - $180,213	-2,673 Reduced 68.31%	1,240 $200 Million
Q1 2021 Jun 17, 2024	BUY	$59.34 - $66.74 $232,197 - $261,153	3,913 New	3,913 $247 Million
Q4 2020 Jun 17, 2024	SELL	$57.74 - $65.43 $5,023 - $5,692	-87 Reduced 2.22%	3,825 $237 Million
Q3 2020 Jun 17, 2024	SELL	$57.43 - $63.64 $7,925 - $8,782	-138 Reduced 3.41%	3,912 $236 Million
Q2 2020 Jun 17, 2024	BUY	$54.82 - $64.09 $222,021 - $259,564	4,050 New	4,050 $238 Million
Q1 2020 Jun 17, 2024	BUY	$46.4 - $67.43 $190,100 - $276,260	4,097 New	4,097 $228 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Traphagen Investment Advisors LLC with notifications on news.